Who's lost more?, page-43

If it is geopolitics and China or some other entities are manipulating the shareprice it's hard for the company to really comment on that. The shareprice was about AUD$3.50 to AUD$4/share when the Ivanhoe deal was announced in March 2022. Four months later in July 2022 the deal was officially called off as at a guess tensions had increased between the US and China given the current chip war etc.. and noting heavy Chinese presence amongst Ivanhoe's top shareholders. So clearly Renergen is going the US route with US DFC finance a a Nasdaq listing. Helium being a strategic asset and China importing like 95% of their helium could be desperate who knows. However hopefully any shenanigans cease once listed on the Nasdaq for which you'd think it's in US interests it goes ahead in a timely fashion. Given helium has been mentioned as being critical to the national security of the US not to mention being vital to numerous industries such as semiconductor manufacturing for which tens of billions have been recently invested into semiconductor manufacturing on US soil to me at a guess the US will ensure the Renergen Nasdaq listing occurs one way or another in the next few months.

Also note the pilot plant is tiny in comparison to Phase 2 which is about x12 the scale plus so the following milestones should be very positive to Renergen in my opinion:

1. CEF funding of about AUD$81m enough to wipe out the US DFC/OPIC loan for Phase One for instance
2. DFC funding for US$500m
3. Funding of US$250m from another bank
4. Nasdaq IPO to raise about US$150m

Then any other x-factor revenues would be a real bonus given Phase 2 isn't till about 2026. Pre-sales of helium via the Argonon Token and/or if anything ever comes of the cryo-vacc.

PS The JSE is closed today